Aquis Stock Exchange: Apex constituent review
Published on 07/20/2026 at 08:00 | dgap.de| Aquis Stock Exchange 20-Jul-2026 / 07:00 GMT/BST The issuer is solely responsible for the content of this announcement. NOTIFICATION OF APEX CONSTITUENT REVIEW Aquis Stock Exchange announces the following changes to the Apex segment of the Aquis Growth Market following the bi-annual constituent review pursuant to Chapter 6 of the Aquis Growth Market Apex Rulebook. The changes are with effect from Monday, 20 July 2026: Market value of securities The following issuer is to be transferred from the Apex segment to the Access segment, as the average market value of the issuer’s securities for the six months prior to the first Friday of June 2026 was less than £10 million: Capital for Colleagues Plc Ordinary Shares Symbol: CFCP ISIN: GB00BGCZ2V99 The Regulation Department Aquis Stock Exchange Level 2, 63 Queen Victoria Street London EC4N 4UA Tel: 0203 597 6361 Email: aqseregulation@aquis.eu Website: www.aquis.eu Dissemination of a CORPORATE NEWS, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. View original content: EQS News |
en | boerse | 69809985 |
